Squarepoint
ABEO icon

Squarepoint’s Abeona Therapeutics ABEO Stock Holding History

Squarepoint’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-21,316
Closed -$113K – 4190
2025
Q3 		$113K Sell
21,316
-120,662
-85% -$765K ﹤0.01% 4087
2025
Q2 		$806K Buy
141,978
+104,037
+274% +$592K ﹤0.01% 2855
2025
Q1 		$181K Buy
37,941
+25,913
+215% +$141K ﹤0.01% 4052
2024
Q4 		$67K Buy
+12,028
New +$74K ﹤0.01% 4790
2024
Q2 		– Sell
-14,520
Closed -$105K – 3979
2024
Q1 		$105K Buy
14,520
+4,520
+45% +$28.6K ﹤0.01% 3789
2023
Q4 		$50.1K Buy
+10,000
New +$44K ﹤0.01% 3848
2022
Q3 		– Sell
-568
Closed -$3K – 2931
2022
Q2 		$3K Buy
568
+77
+16% +$390 ﹤0.01% 2806
2022
Q1 		$4K Hold
491
– – ﹤0.01% 2734
2021
Q4 		$4K Buy
+491
New +$9.02K ﹤0.01% 3108
2021
Q2 		– Sell
-532
Closed -$25K – 3158
2021
Q1 		$25K Sell
532
-1,949
-79% -$107K ﹤0.01% 3021
2020
Q4 		$97K Sell
2,481
-1,331
-35% -$45.3K ﹤0.01% 2727
2020
Q3 		$97K Buy
3,812
+2,920
+327% +$184K ﹤0.01% 2296
2020
Q2 		$65K Sell
892
-88
-9% -$6.08K ﹤0.01% 2073
2020
Q1 		$51K Buy
+980
New +$65.5K ﹤0.01% 1718
2019
Q3 		– Sell
-1,970
Closed -$235K – 2294
2019
Q2 		$235K Buy
+1,970
New +$330K ﹤0.01% 2044
2019
Q1 		– Sell
-475
Closed -$85K – 2100
2018
Q4 		$85K Sell
475
-437
-48% -$95.3K ﹤0.01% 1811
2018
Q3 		$292K Buy
+912
New +$324K ﹤0.01% 1552

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Squarepoint's ABEO Position: Q4 2025 in Review

Squarepoint sold out of Abeona Therapeutics (ABEO) in Q4 2025, closing a stake of 21,316 shares — an estimated $113K sold.

Squarepoint first reported a position in ABEO in Q3 2018 and held it in 17 quarters. The position peaked at $806K in Q2 2025. 104 funds tracked by Wall St. Rank hold ABEO as of Q4 2025.

  • Squarepoint reported no remaining Abeona Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Squarepoint sold 21,316 Abeona Therapeutics shares in Q4 2025, an estimated $113K.
  • Squarepoint first reported a position in Abeona Therapeutics in Q3 2018 and held it in 17 quarters.
  • Squarepoint's Abeona Therapeutics position peaked at $806K in Q2 2025.
  • 104 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2025.

Based on Squarepoint's 13F filing for Q4 2025, filed 13 Feb 2026.